SEC Form 4 · accession 0001615774-16-007983
Emmaus Life Sciences, Inc. · EMMA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas T Tierney
Director · 10% Owner
Period of report
Nov 1, 2016
Accepted (ET)
Nov 2, 2016 · 9:11 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000822370
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 1, 2016 | A | 20,000 | $0.00 | A | 20,000 | D | |
| Common StockF2 | holding | — | — | — | 184,345 | I | Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The award was approved by the board of directors of MYnd Analytics, Inc. (the "Registrant") on September 29, 2016, subject to stockholder approval of the Amended and Restated 2012 Omnibus Incentive Compensation Plan (the "Plan") under which the award was granted. The Registrant's stockholders approved the Plan on November 1, 2016.
- F2Securities are held in the name of the Thomas T. and Elizabeth C. Tierney Family Trust of which Mr. Tierney is a trustee.